JP

Julien Pham

Founder & Managing Partner | Physician-led Healthtech Investor Fund

Boston, Massachusetts

Overview 

Julien Pham is the Founder and Managing Partner of Third Culture Capital, a physician-led Healthtech VC Fund based in Boston, Massachusetts. With a background in clinical research and medicine, Julien has successfully invested in various healthtech startups, demonstrating expertise in venture capital and innovation consulting. Notable highlights of Julien's career include founding Third Culture Capital and investing in a range of healthtech companies, showcasing a strong commitment to supporting diverse founders and advancing healthcare innovation through strategic investments.

Work Experience 

  • Founder & Managing Partner

    2020 - Current

    3CC | Third Culture Capital is an immigrant-founded, physician-led, and diversity-certified healthtech and techbio VC fund based in Boston that invests in founders whose diversity of thought, from different cultures, identities, and lived experiences, makes them “uniquely qualified” to rewire care delivery for the world. We deploy 3 forms of capital: - Human capital - Financial capital - Cultural capital We believe that high-quality healthcare for every human is ACHIEVABLE when DIVERSE entrepreneurs have FAIR & EQUITABLE access to capital, to unlock markets and generate outsized returns.

Immigrant-founded, physician-led, and diversity-certified seed-stage VC firm focused on emerging healthtech and techbio companies

  • Investor

    2024

  • Investor

    2023

Zuri Fertility is a patient-centered hassle-free and digital fertility clinic.

Raised $878,000.00 from 3CC | Third Culture Capital.

  • Investor

    2023

Binkey is a financial technology company that helps merchants to accepts FSA and HSA as a form of payment.

Raised $3,300,000.00 from Wellington Management, 3CC | Third Culture Capital, Plug and Play and SpringTide Ventures.

  • Investor

    2023

  • Investor

    2022

Ciba Health offers a personalized digital therapeutics and virtual care platform.

Raised $12,000,000.00 from 3CC | Third Culture Capital, E12 Ventures, Plug and Play and DigiTx Partners.

  • Investor

    2022

  • Investor

    2022

Pragma Bio is a biotechnology company that mines microbiome drugs to treat cancer and autoimmune diseases.

Raised $14,515,000.00 from Iaso Ventures, Good AI Capital, CJ Investment, Merck Global Health Innovation Fund, Viking Global Investors and The Venture Collective.

  • Investor

    2022

KeyWise AI develops an artificial intelligence software tracks brain function objectively and precisely.

  • Investor

    2022

AcousticaBio is a company that has developed a means to reformulate intravenous medications.

Raised $150,000.00 from 3CC | Third Culture Capital, PROTOCOL — by GETTYLAB and Reinforced Ventures.

Articles About Julien

Relevant Websites